Medtronic Sprint Fidelis Defibrillation Leads
Defibrillation Leads Can Fracture and Cause Serious Injuries Including Death
Medtronic Inc. has removed its Sprint Fidelis defibrillation leads from the market after five patient deaths have been linked to the devices. Medtronic said that the defibrillator lead can fracture and may have been a contributing factor in the deaths. A fracture in the defibrillator lead can cause a defibrillator to deliver unnecessary shocks to the heart or not operate at all. Defibrillators are used to regulate a persons heartbeat. The device can sense an abnormal heart rhythm and then deliver an electronic shock to reset the heart to a normal beat. A defibrillation system consists of a device implanted near the shoulder with one or more leads connecting the device to the heart. Medtronic has begun asking doctors to stop implanting the leads and return all unused leads to Medtronic.
Medtronic said the following models of Sprint Fidelis Leads are at risk or fracture:
- Sprint Fidelis 6930
- Sprint Fidelis 6931
- Sprint Fidelis 6948
- Sprint Fidelis 6949
Representing Medtronic Sprint Fidelis Defibrillator Lead Patients Nationwide
If you or a loved one has a debibrillator implanted that uses a recalled Medtronic Spring Fidelis lead, you may have valuable rights.
To receive a FREE Medtronic Sprint Fidelis consultation, contact our experienced defective medical device attorneys today.
Mark & Associates, P.C. represents all defective medical device clients on a contingency basis. This means there are NO legal fees unless we win compensation in your case. Call 1-866-50-RIGHTS (1-866-507-4448) or fill out our online Medtronic Sprint Fidelis case review form today.Topic Video
Topic Quick Look
What are the risks?
Medtronic estimated that about 4,000 to 5,000 patients with the Fidelis lead will experience a lead fracture within 30 months of implantation.
Medtronic will not pay for procedures to replace functioning leads that patients want taken out to head off potential problems.
